News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
468,455 Results
Type
Article (37508)
Company Profile (178)
Press Release (430769)
Section
Business (128492)
Career Advice (1075)
Deals (21655)
Drug Delivery (97)
Drug Development (45874)
Employer Resources (159)
FDA (11504)
Job Trends (11563)
News (213410)
Policy (22772)
Tag
Academia (2525)
Alliances (35153)
Alzheimer's disease (960)
Approvals (11459)
Artificial intelligence (126)
Bankruptcy (171)
Best Places to Work (9775)
Biosimilars (69)
Biotechnology (107)
Breast cancer (82)
Cancer (662)
Cardiovascular disease (73)
Career advice (954)
Cell therapy (146)
Clinical research (35960)
Collaboration (306)
COVID-19 (2338)
C-suite (77)
Data (717)
Diabetes (117)
Diagnostics (5295)
Drug pricing (86)
Earnings (39751)
Employer resources (136)
Events (82081)
Executive appointments (233)
FDA (11892)
Funding (268)
Gene therapy (116)
GLP-1 (454)
Government (4267)
Healthcare (15946)
Infectious disease (2419)
Inflammatory bowel disease (88)
Interviews (147)
IPO (9069)
Job creations (2124)
Job search strategy (851)
Layoffs (239)
Legal (4429)
Lung cancer (115)
Manufacturing (137)
Medical device (9974)
Medtech (9978)
Mergers & acquisitions (12674)
Metabolic disorders (325)
Neuroscience (1160)
NextGen Class of 2024 (5675)
Non-profit (4285)
Northern California (990)
Obesity (200)
Opinion (141)
People (42572)
Phase I (11381)
Phase II (14509)
Phase III (12736)
Pipeline (307)
Postmarket research (1744)
Preclinical (4378)
Radiopharmaceuticals (164)
Rare diseases (155)
Real estate (4144)
Regulatory (15029)
Research institute (2188)
Resumes & cover letters (131)
Southern California (772)
Startups (2843)
United States (9258)
Vaccines (496)
Weight loss (143)
Date
Today (142)
Last 7 days (683)
Last 30 days (2594)
Last 365 days (25906)
2024 (23365)
2023 (28982)
2022 (38631)
2021 (42380)
2020 (42146)
2019 (37764)
2018 (28218)
2017 (21795)
2016 (22794)
2015 (25848)
2014 (19654)
2013 (16160)
2012 (17331)
2011 (17756)
2010 (16110)
Location
Africa (652)
Arizona (117)
Asia (25900)
Australia (4633)
California (2065)
Canada (914)
China (167)
Colorado (112)
Connecticut (119)
Europe (59355)
Florida (305)
Georgia (96)
Illinois (269)
Indiana (177)
Kansas (76)
Maryland (416)
Massachusetts (1695)
Michigan (121)
Minnesota (173)
New Jersey (700)
New York (701)
North Carolina (538)
Northern California (990)
Ohio (96)
Pennsylvania (587)
South America (864)
Southern California (772)
Texas (259)
Utah (80)
Washington State (272)
468,455 Results for "usana health sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Linear Health Sciences Reports Clinical, Commercial Milestones
Medical device company Linear Health Sciences today announced multiple clinical and commercial milestones for its Orchid SRV™ , a breakaway safety valve designed to improve the use of medical tubing in hospitals.
June 26, 2024
·
3 min read
Deals
Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023
Seres Therapeutics, Inc., announced that it has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with VOWST capsules.
June 6, 2024
·
4 min read
Deals
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science
Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide Nestlé Health Science with full VOWST product and related intellectual property rights.
June 6, 2024
·
5 min read
BioMidwest
Linear Health Sciences Publishes Whitepaper Examining IV Dislodgement
Linear Health Sciences announced the publication of a new whitepaper on accidental dislodgement of IV catheter lines.
March 27, 2024
·
3 min read
Policy
Women’s Health: Where Politics and Science Meet
On this episode of Denatured, Lori Ellis and guests discuss President Biden’s Executive Order on Advancing Women’s Health Research and Innovation and the outlook of investment in women’s health.
May 8, 2024
·
1 min read
Business
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
Guardion Health Sciences, Inc. announced its financial results for the year ended December 31, 2023.
March 29, 2024
·
10 min read
Pharm Country
Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection
Origin Life Sciences, Inc. announced that the Company’s abstract, titled: “NO: a Novel, Pathogen-Agnostic Therapy for Treatment-Resistant Wound Infections in the Warfighter,” has been accepted for presentation at 2024 Military Health System Research Symposium.
June 11, 2024
·
6 min read
Press Releases
Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30
September 27, 2024
·
4 min read
Pharm Country
Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
Anavex Life Sciences Corp. today announced that it will present at the 44th Annual TD Cowen Health Care Conference, March 4-6, 2024.
February 26, 2024
·
3 min read
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA®
AffaMed Therapeutics today announced that the Singapore Health Sciences Authority (HSA) has accepted its New Drug Application (NDA) for DEXTENZA®.
February 19, 2024
·
3 min read
1 of 46,846
Next
